Azilsartan Medoxomil Tablet
Product Images NDC 52536-004

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Azilsartan Medoxomil (NDC 52536-004). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wilshire Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

40mg-label (Azilsartan Medoxomil 40mg Label Rev00)

Azilsartan Medoxomil Tablets 40 mg oral tablets packaging label with a quantity of 30 tablets. The label specifies storage instructions, ingredient equivalence, and manufacturer information: Wilshire Pharmaceuticals, Inc. in Atlanta, GA, and Takeda in Ireland. Includes NDC 52536-004-03 and a barcode.*

FDA Label Image

80mg-label (Azilsartan Medoxomil 80mg Label Rev00)

Azilsartan Medoxomil Tablets 80 mg label showing a package of 30 tablets. The white tablet strength is noted as 80 mg azilsartan medoxomil. The label includes manufacturer information: Wilshire Pharmaceuticals, Inc. and Takeda, Ireland. Storage instructions and a barcode are also visible.*

FDA Label Image

Figu-1 (Figure 01)

A pharmacokinetic chart displaying fold change and 90% confidence intervals for Azilsartan Medoxomil across various population subgroups, including age, gender, race, renal and hepatic impairment, and pediatric use. The chart compares Cmax and AUC values relative to reference, accompanied by dosing recommendations, mostly indicating no dose adjustment is necessary.*

FDA Label Image

Figu-2 (Figure 2)

This image contains two line graphs comparing systolic and diastolic blood pressure over 24 hours postdose for Azilsartan medoxomil 80 mg, placebo, Olmesartan 40 mg, and Valsartan 320 mg. The top graph shows systolic blood pressure trends, while the bottom graph shows diastolic blood pressure trends, with Azilsartan medoxomil generally exhibiting lower blood pressure values compared to other treatments and placebo.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of Azilsartan kamedoxomil, the active ingredient in Azilsartan Medoxomil tablets. The structure includes multiple ring systems and functional groups, characteristic of this compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.